TKI Hikes Survival in Recurrent Ovarian Cancer
Cediranib, bevacizumab, and novel antiangiogenic agents continue to improve survival in first-line and recurrent ovarian cancer, as reported by Dr. Stanley Kaye from ECC 2013. (Source: Medscape Oncology)
Source: Medscape Oncology - October 4, 2013 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
TKI Hikes Survival in Recurrent Ovarian Cancer
Cediranib, bevacizumab, and novel antiangiogenic agents continue to improve survival in first-line and recurrent ovarian cancer, as reported by Dr. Stanley Kaye from ECC 2013. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - October 4, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
TKI Hikes Survival in Recurrent Ovarian Cancer
Cediranib, bevacizumab, and novel antiangiogenic agents continue to improve survival in first-line and recurrent ovarian cancer, as reported by Dr. Stanley Kaye from ECC 2013. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - October 4, 2013 Category: OBGYN Authors: Medscape Source Type: podcasts
Ovarian Cancer Web Chat with Dana-Farber Expert Ursula Matulonis, MD
Dana-Farber/Brigham and Women's Cancer Center gynecologic oncology expert, Ursula A. Matulonis, MD, presents an overview on the latest in ovarian cancer treatment on CancerConnect. Dr. Matulonis is th...
Author: cancerconnectasktheexpert
Added: 09/19/2013 (Source: Oncology Tube)
Source: Oncology Tube - September 19, 2013 Category: Cancer & Oncology Source Type: podcasts
Sonographic Follow-up of Ovarian Masses
Dr. Andrew Kaunitz explains how ultrasonography can be used to minimize the use of surgery in managing asymptomatic women who have abnormal ovarian findings. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - September 17, 2013 Category: OBGYN Authors: Medscape Source Type: podcasts
Ovarian cancer screening with simple blood test
Download from iTunes: https://itunes.apple.com/us... A simple blood test currently approved to detect ovarian cancer disease recurrence is...
Author: mdanderson
Added: 09/10/2013 (Source: Oncology Tube)
Source: Oncology Tube - September 10, 2013 Category: Cancer & Oncology Source Type: podcasts
Comorbidities: Prequel or Sequel to Cancer?
Dr. Maurie Markman reports provocative findings about the prevalence of comorbid conditions in women with ovarian cancer and what they mean to clinical trials -- and the patients enrolled in them. (Source: Medscape General Surgery Podcast)
Source: Medscape General Surgery Podcast - September 9, 2013 Category: Surgery Authors: Medscape Source Type: podcasts
Comorbidities: Prequel or Sequel to Cancer?
Dr. Maurie Markman reports provocative findings about the prevalence of comorbid conditions in women with ovarian cancer and what they mean to clinical trials -- and the patients enrolled in them. (Source: Medscape Oncology)
Source: Medscape Oncology - September 9, 2013 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
IP Therapy Extends Survival in Ovarian Cancer
Dr. Maurie Markman reports on a study showing that long-term survival (> 9 years) is possible in stage 3 ovarian cancer, but skilled specialists and state-of-the-art therapies are important factors. (Source: Medscape Oncology)
Source: Medscape Oncology - August 26, 2013 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer
Gynecologic oncologist Oliver Zivanovic describes the use of heated intraperitoneal chemotherapy to treat ovarian cancer.
Author: mskcc
Added: 08/14/2013 (Source: Oncology Tube)
Source: Oncology Tube - August 14, 2013 Category: Cancer & Oncology Source Type: podcasts
ASCO 2013 - Maintenance Olaparib for Severe Ovarian Cancer and a BRCA mutation - Dr. Jonathan Ledermann
Abstract #5505: Previously, we reported that maintenance treatment with the oral PARP inhibitor olaparib (400 mg bid) led to a significant PFS improvement vs placebo in patients (pts) with platinum-se...
Author: oncologyeducation
Added: 06/23/2013 (Source: Oncology Tube)
Source: Oncology Tube - June 23, 2013 Category: Cancer & Oncology Source Type: podcasts
Cervical Cancer Studies Take Center Stage
Dr. Maurie Markman predicts that ASCO 2013 will be a hotbed for gynecologic cancer research, including highly anticipated studies in ovarian cancer and plenary-featured studies in cervical cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - May 23, 2013 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
